ICD-116D32	PEDOPHILIC DISORDER Pedophilic disorder
ICD-10F65.4	Paedophilia
DSM-5-TRF65.4	Pedophilic Disorder

1. Definition and nosology

Paedophilic Disorder (ICD-11: 6D32 Pedophilic Disorder; DSM-5-TR: F65.4) — persistent and intense sexual arousal toward prepubescent children (typically <13 years) for ≥6 months; the patient has acted on fantasies involving children or experiences significant distress/functional impairment. Patient is at least 16 years and victim at least 5 years younger.

Important: “Pedophilic interest” (paraphilia) and “Pedophilic Disorder” (clinical diagnosis) are distinct — the diagnosis requires functional impairment and/or harm to the child.

2. History

• Krafft-Ebing (1886).
• DSM-III (1980).
• WFSBP 2020 — international guideline for paraphilic disorders.

3. Epidemiology

• Prevalence — precise data are hard to obtain (stigmatised category); DSM-5-TR gives 3–5% as the highest possible figure in the male population; true pedophilic preference ~1%.
• Sex: almost always in males.
• Comorbidity: other paraphilic, ASPD, MDD, anxiety, substance use.

4. Aetiology and pathogenesis

• Biological — neurodevelopmental anomalies (Cantor J.M. reviews — IQ, neuroanatomical differences).
• History of childhood trauma or sexual abuse (but most individuals with pedophilic disorder were not victims themselves; the “abused-abuser” concept is semi-scholarly).
• Comorbid impulsivity and hypersexuality.

5. Clinical features

• Persistent and intense sexual arousal toward prepubertal children.
• The patient has acted on fantasy (sexual abuse of a child) or experiences distress/functional impairment.
• Subtypes (DSM-5-TR): exclusive type (attracted only to children), nonexclusive type (attracted to both children and adults); male/female/both.
• Legal consequences (crime).

6. Diagnosis

6.1 Unified diagnostic criteria

A. ≥6 months repeated and intense sexual arousal towards prepubertal children (typically ≤13).

B. The patient has acted on fantasy or experiences significant distress/functional impairment.

C. Patient ≥ 16 years old and at least 5 years older than the child.

6.2 Source-specific clarifications

• DSM-5-TR requires a 6-month duration and an age rule (patient ≥16 years and at least 5 years older than the child); ICD-11 has neither a duration nor an age criterion — it only excludes behaviour between peers close in age.
• WFSBP 2020.
• Structured risk assessment in forensic psychiatry context.

6.3 Diagnostic algorithm

1. Clinical interview (difficult to confess; patient may conceal).
2. Penile plethysmography — investigation and forensic context.
3. Forensic risk assessment (Static-99R, STABLE-2007).
4. Comorbidity.

6.4 Differential diagnosis

7. Examination and assessment

• Forensic clinical interview.
• Static-99R, STABLE-2007.
• Penile plethysmography (investigation).
• Comorbidity.

8. Treatment

8.1 General Principles (WFSBP 2020 Stepwise)

1. CBT and prevention of relapse — first-line; trigger management, management of cognitive distortions, empathy development.
2. SSRI high dose — first pharmacotherapy — reduces impulsivity and sexual urge.
3. Antiandrogen (CPA, MPA) — in moderate-to-severe cases; libido and sexual activity decrease.
4. GnRH agonist (leuprolide, triptorelin) — chemical castration; in most severe or high-risk cases; continuous monitoring (osteoporosis, metabolic).
5. Forensic intervention and community monitoring parallel.
6. Multidisciplinary approach — psychiatrist, therapist, social service, legal.

8.2 Source-specific clarifications

• WFSBP 2020 — Thibaut et al. — step‑by‑step pharmacotherapy.
• STABLE-2007 – dynamic risk factors.

Treatment methods

1. CBT and Relapse Prevention — Trigger and context management; cognitive distortion; empathy training.
2. SSRI High Dose — First pharmacotherapy.
3. Antiandrogen (CPA, MPA) — Libido reduction.
4. GnRH Agonist — Chemical castration; ongoing monitoring.
5. Static-99R, STABLE-2007 — Forensic risk assessment.

9. Prognosis

• Behavior management improves with evidence-based treatment.
• Comorbid ASPD and substance use — poor prognosis.
• Continuous monitoring critical.

10. Myths and misconceptions

Myth 1: “Pedophilic interest always means child abuse”

Evidence: “Having pedophilic fantasies” and “committing child abuse” are different; some patients never abuse and seek clinical support (e.g., “Dunkelfeld” program in Germany).

Myth 2: “All child sexual abusers are pedophilic”

Evidence: Most child sex offenders are not pedophilic — the offence is situational, with other motivations. Pedophilic diagnosis requires persistent sexual arousal for ≥ 6 months.

Myth 3: “Chemical castration should be mandatory for all patients”

Evidence: WFSBP 2020 step‑by‑step approach — GnRH in most severe cases; CBT and SSRI first. Ethical and legal caution.

Myth 4: “Once a pedophile, always a pedophile”

Evidence: Sexual interest may be stable, but behavioral control can significantly improve with CBT and pharmacotherapy.

Myth 5: “Treatment is ineffective”

Evidence: WFSBP 2020 and meta‑analyses — multimodal intervention reduces recidivism

Myth 6: “The patient is a ‘victim’ of childhood trauma”

Evidence: “Abused-abuser” concept not fully supported; most patients were not abused in childhood; victimhood is not the basis for perpetration.

11. Sources

1. WHO. ICD-11. 6D32 Pedophilic disorder. 2024.
2. APA. DSM-5-TR. 2022.
3. Thibaut F., Cosyns P., Fedoroff J.P. et al.; WFSBP Task Force on Paraphilias. The World Federation of Societies of Biological Psychiatry (WFSBP) 2020 guidelines for the pharmacological treatment of paraphilic disorders. World J Biol Psychiatry 2020;21(6):412–490.
4. Cantor J.M. et al. Cerebral white matter deficiencies in pedophilic men. J Psychiatr Res 2008;42(3):167–183.
5. Beier K.M. et al. Encouraging self-identified pedophiles and hebephiles to seek professional help (Prevention Project Dunkelfeld). Child Abuse Negl 2009;33(8):545–549.